Ketamine Withdrawn Phase 3 Trials for Major Depressive Disorder (MDD) Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science3
clinicaltrials.gov IdentifierTitleDrugs
NCT03051945Endogenous Opioid Modulation by Ketamine